The Hemotherapy and Hemostasis Service is part of the Clinical Institute of Hematological and Oncological Diseases (ICMHO). It provides comprehensive care for patients with hemorrhagic and thrombotic diseases or congenital erythrocyte pathology. Its activity also includes antithrombotic treatments, obtaining hematopoietic progenitors for the ICMHO Bank or for advanced therapies and carrying out therapeutic apheresis.

It is structured in two sections:

  • Hemotherapy Section. The Haemotherapy section performs plasma replacements, in which the patient's plasma is replaced, in the context of autoimmune diseases, microangiopathies, hypercholesterolemia, parasite infection or poisoning, and in the context of immunoadsorption procedures, such as in transplants with ABO incompatibility. This section also performs cytoapheresis, in the treatment of graft-versus-host disease, in which hematopoietic progenitors, platelets, or leukocytes are collected. This collection may also be for photoapheresis.
  • Hemostasis section. This section provides care to patients with coagulation disorders in outpatient, inpatient and Day Hospital consultations, and includes the administration of blood products. It carries out the diagnosis, treatment, training and follow-up of patients with bleeding problems, including haemophilia, thrombotic disease or antithrombotic treatment. The Erythropathology Consultation carries out the diagnosis and treatment of rare erythrocyte diseases.

What are we dealing with?

These are the main health issues that are treated in the Hemotherapy and Hemostasis Service.

Last year in numbers

Know the team

The Service is made up of administrative, nursing and hematology specialists, specifically in the field of haemotherapy and haemostasis. There are two administrators, one of whom is located in the Day Hospital and the other, on the side of the Service Headquarters. The Day Hospital has three nurses and the Apheresis Unit has seven. There are two section heads, one for each. The hemotherapy area is made up of two hematology specialists and the hemostasis area is made up of five

Juan Carlos Reverter Head of Service
Content prepared with the collaboration of:

Testimonials

First-person Acute Myeloid Leukemia

Appointment of Thomas, Patient
It's not an easy process, of course not, I don't think it's a question of deception. It takes a lot of patience and the road is full of obstacles. But with optimism, enthusiasm and a strong desire to fight, it can clearly be overcome.

Lymphoma in the first person

Appointment of Francesc, Patient
One should accept the treatment and trust the doctors and not get obsessed by illness or health. One should also try to make an effort to talk openly about the illness with the doctors and friends, and to ask any questions that might be of concern.